Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$98,339,041
+$54,561,842 QoQ
Shares Held
583,476
+75.6% QoQ
Ownership
0.574%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#30
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $624,876,791 across 66 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
9,213,269 | $133,500,266 | |
| 2 | ZTS |
Zoetis Inc.
|
1,828,326 | $131,383,499 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
583,476 | $98,339,041 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
10,832,582 | $53,404,627 | |
| 5 | VTRS |
Viatris Inc
|
3,135,460 | $49,791,098 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
62,600 | $33,918,552 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
953,413 | $32,301,629 | |
| 8 | HLN |
Haleon plc
|
3,385,489 | $31,586,609 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,339,041 | 583,476 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $43,777,199 | 332,300 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,110,828 | 311,012 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $34,347,613 | 244,676 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $15,227,592 | 121,152 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $9,158,784 | 82,810 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $8,269,988 | 60,586 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $29,140,287 | 252,910 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,774,607 | 165,429 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $19,167,290 | 138,974 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $16,146,788 | 122,547 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,414,398 | 48,128 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,139,294 | 43,895 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $11,915,920 | 117,723 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,494,281 | 121,352 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,097,103 | 113,898 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,520,527 | 107,925 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,687,653 | 71,335 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,240,082 | 61,525 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,730,428 | 59,748 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,567,054 | 67,479 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,012,286 | 61,823 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $5,519,137 | 57,581 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,018,524 | 41,790 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,619,496 | 29,668 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,393,278 | 27,652 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||